PledPharma AB (PLED):企業の財務・戦略的SWOT分析

◆英語タイトル:PledPharma AB (PLED) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH135846FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PledPharma AB (PledPharma) is a pharmaceutical company that discovers, manufactures, and develops drugs that protect the body against oxidative stress. The company discovers and develops Aladote and PledOx drugs. PledOX drug is used to prevent chemotherapy-induced side effects for colorectal cancer. PledPharma’s products are also used in therapeutic areas such as oncology and cardiology. The company also evaluates derivatives for conditions related to oxidative stress during the treatment of life-threatening diseases and also develops pharmaceuticals based on PLED substances. It also provides treatment for life-threatening illnesses based on PLED technologies. PledPharma is headquartered in Stockholm, Sweden.

This comprehensive SWOT profile of PledPharma AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PledPharma AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

PledPharma AB – Key Information
PledPharma AB – Overview
PledPharma AB – Key Employees
PledPharma AB – Key Employee Biographies
PledPharma AB – Key Operational Heads
PledPharma AB – Major Products and Services
PledPharma AB – History
PledPharma AB – Company Statement
PledPharma AB – Locations And Subsidiaries
PledPharma AB
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

PledPharma AB – Business Description
PledPharma AB – Corporate Strategy
PledPharma AB – SWOT Analysis
SWOT Analysis – Overview
PledPharma AB – Strengths
PledPharma AB – Weaknesses
PledPharma AB – Opportunities
PledPharma AB – Threats
PledPharma AB – Key Competitors

Section 3 – Company Financial Performance Charts

PledPharma AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

PledPharma AB, Key Information
PledPharma AB, Key Ratios
PledPharma AB, Share Data
PledPharma AB, Major Products and Services
PledPharma AB, History
PledPharma AB, Key Employees
PledPharma AB, Key Employee Biographies
PledPharma AB, Key Operational Heads
PledPharma AB, Other Locations
PledPharma AB, Subsidiaries
PledPharma AB, Key Competitors
PledPharma AB, SWOT Analysis
PledPharma AB, Ratios based on current share price
PledPharma AB, Annual Ratios
PledPharma AB, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[PledPharma AB (PLED):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TrialBee AB:製薬・医療:M&Aディール及び事業提携情報
    Summary TrialBee AB (TrialBee) is a provider of innovative software solutions that accelerates clinical trials. The company provides services such as online patient recruitment, online study feasibility, study retention and electronic data capture, among others. It offers cloud based solution which …
  • Envision Healthcare Corp:企業のM&A・事業提携・投資動向
    Envision Healthcare Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Envision Healthcare Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析
    Summary Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a …
  • North Pacific Bank,Ltd:企業の戦略・SWOT・財務情報
    North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report Summary North Pacific Bank,Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Heerema International Group Services SA:企業の戦略的SWOT分析
    Heerema International Group Services SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Oando Plc (OANDO):企業の財務・戦略的SWOT分析
    Oando Plc (OANDO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Supreme Group B.V.
    Supreme Group B.V. - Strategy, SWOT and Corporate Finance Report Summary Supreme Group B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Elekta AB (EKTA B):医療機器:M&Aディール及び事業提携情報
    Summary Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotact …
  • Enbridge Inc.:戦略・SWOT・企業財務分析
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Immunocore Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Immunocore Ltd (Immunocore) is a biotechnology company that focuses on the development of immunotherapeutic drugs for the treatment of cancer, infectious diseases and autoimmune diseases. The company develops its drugs using its proprietary T cell receptor (TCR) technology. Its products unde …
  • Ache Laboratorios Farmaceuticos SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that provides generic products. The company offers prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products, among others. It offers activities such as research, developmen …
  • Synthetic Biologics Inc (SYN):企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • Sirona Biochem Corp (SBM):企業の財務・戦略的SWOT分析
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It offers cosmeceutical programs such as development of anti-aging and depigmenting agents, …
  • NMDC Ltd:企業の戦略・SWOT・財務情報
    NMDC Ltd - Strategy, SWOT and Corporate Finance Report Summary NMDC Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Elders Limited:企業の戦略・SWOT・財務情報
    Elders Limited - Strategy, SWOT and Corporate Finance Report Summary Elders Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • African Phoenix Investments Ltd:企業の戦略・SWOT・財務分析
    African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • EMD Serono Inc-製薬・医療分野:企業M&A・提携分析
    Summary EMD Serono Inc (EMD), formerly Serono Inc, a subsidiary of Merck KGaA is a healthcare products provider that offers oncology products. The company offers neurology and immunology; metabolic endocrinology, fertility and oncology products. It offers neurology and immunology products to find ne …
  • Leadiant Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Leadiant Biosciences Inc (Leadiant Biosciences), formerly Sigma-Tau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matu …
  • United States Cellular Corp (USM):企業の財務・戦略的SWOT分析
    United States Cellular Corp (USM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Newcastle University-製薬・医療分野:企業M&A・提携分析
    Summary Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri- …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆